Want to join the conversation?
In 3Q16, $CMN saw Endoscopy sales of $91.9MM. Adjusted operating profit increased by over 42% due to strong volumes in all product categories. The company expects investments in international markets to accelerate growth of endoscopy products and support direct sales efforts in major markets such as the UK, Italy, Germany, France and China.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.